High dose intravenous, but not low dose subcutaneous, insulin-like growth factor-I therapy induces sustained insulin sensitivity in severely resistant type I diabetes mellitus

1994 ◽  
Vol 79 (2) ◽  
pp. 435-440 ◽  
Author(s):  
A. L. Usala
Keyword(s):  
Diabetes Mellitus ◽  
Insulin Sensitivity ◽  
Growth Factor ◽  
Low Dose ◽  
Type I Diabetes ◽  
Type I Diabetes Mellitus ◽  
High Dose ◽  
Type I ◽  
Subcutaneous Insulin ◽  
Factor I

Improved Insulin Sensitivity in Patients with Type I Diabetes Mellitus After CSII

Diabetes ◽  
1985 ◽  
Vol 34 (Supplement_3) ◽  
pp. 80-86 ◽  
Author(s):  
D. C. Simonson ◽  
W. V. Tamborlane ◽  
R. S. Sherwin ◽  
J. D. Smith ◽  
R. A. DeFronzo ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Insulin Sensitivity ◽  
Type I Diabetes ◽  
Type I Diabetes Mellitus ◽  
Type I

Comparison of intraperitoneal and subcutaneous insulin administration on lipids, apolipoproteins, fuel metabolites, and hormones in type I diabetes mellitus

Metabolism ◽  
1989 ◽  
Vol 38 (9) ◽  
pp. 908-912 ◽  
Author(s):  
Jean-Louis Selam ◽  
Moti Kashyap ◽  
KGMM Alberti ◽  
James Lozano ◽  
Michael Hanna ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type I Diabetes ◽  
Type I Diabetes Mellitus ◽  
Type I ◽  
Subcutaneous Insulin ◽  
Insulin Administration

scholarly journals Analytical Comparison of Continuous Subcutaneous Insulin Infusion and Multiple Daily Injections in Children and Adolescents with Type I Diabetes Mellitus

2020 ◽  
Vol 6 (2) ◽  
Author(s):  
Siddig AA ◽  
Bui TDMP ◽  
Readon DR ◽  
Ven M ◽  
Bailes Z ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Continuous Subcutaneous Insulin Infusion ◽  
Insulin Infusion ◽  
Type I Diabetes ◽  
Type I Diabetes Mellitus ◽  
Type I ◽  
Subcutaneous Insulin ◽  
Children And Adolescent ◽  
Multiple Daily Insulin Injections ◽  
Better Than

Introduction: Continuous subcutaneous insulin infusion (CSII) is a form of insulin administration for patients with type I diabetes mellitus (T1DM) that was introduced as a means of stimulating normal plasma insulin fluctuations and provide better metabolic control that is better than multiple daily insulin injections (MDI). The purpose of this study was to determine the effect of CSII as compared to MDI in the treatment of T1DM in children and adolescent below 20 years of age.

scholarly journals Effects of low dose metformin in adolescents with type I diabetes mellitus: a randomized, double-blinded placebo-controlled study

2014 ◽  
Vol 16 (3) ◽  
pp. 196-203 ◽  
Author(s):  
Kristen J Nadeau ◽  
Kelsey Chow ◽  
Suhyla Alam ◽  
Kara Lindquist ◽  
Sarah Campbell ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Low Dose ◽  
Type I Diabetes ◽  
Type I Diabetes Mellitus ◽  
Controlled Study ◽  
Type I ◽  
Double Blinded
Sign in / Sign up

Export Citation Format

Share Document